The Nasdaq Biotechnology Index Closed Down 2%, With Component Stocks Jyong Biotech Down 20.95%, Bridgebio Pharma Down 15.21%, Sionna Therapeutics Down 15.12%, Abcellera Biologics Down 14.98%, And Editas Medicine Down 14.62%. Gilead Sciences, However, Performed Relatively Well, Closing Up 2.15%, With Silence Therapeutics Up 5.12%, Erasca Up 5.69%, And Phibro Animal Health Up 22.02%

[Ethereum'S 24-Hour Price Drop Widens To 15%, Now Down To $1824] February 6, According To Htx Market Data, Ethereum'S 24-Hour Decline Has Widened To 15%, Now Falling To $1824, With A Market Cap Of $222.57 Billion

[Spot Gold Plunges $50 Intraday, Down 1.05%] February 6Th, According To Bitget Market Data, Spot Gold Fell By $50 Intraday, Now Trading At $4729.39 Per Ounce, Down 1.05%

Japan's Nikkei Average Futures Down 0.7 % In Early Trade

Japan December Household Spending Fall 2.6% Year On Year

Nikkei Futures Trade At 53795 Versus Cash Close Of 53,818

Australia's S&P/ASX 200 Index Down 1.36% At 8768.30 Points In Early Trade

In Early Asian Trading On Friday, NASDAQ 100 Futures Fell 0.8% And S&P 500 Futures Fell 0.5%